跳至主要内容
临床试验/NCT07569302
NCT07569302尚未招募2 期

Triggering Ovulation in Normo-responders Using a Modified Dual Trigger Protocol or HCG Trigger . A Randomized Controlled Study

Bedaya Hospital1 个研究点 分布在 1 个国家目标入组 196 人开始时间: 2026年6月1日最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
196
试验地点
1

研究概览

简要总结

The aim of this randomized controlled study is to compare the efficacy of a modified dual trigger protocol [a single bolos of HCG combined with two successive doses of a GnRH agonist ] with HCG [a single bolos administered 36 hours before oocyte retrieval ] in triggering ovulation in normo-responders undergoing ovarian stimulation using the antagonist protocol.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • GnRH antagonist IVF cycle
  • Normo-responders to induction of ovulation

排除标准

  • Hypogonadotrophic hypogonadism
  • Endometriosis
  • History of recurrent abortion

研究组 & 干预措施

Modified dual trigger group

Experimental

HCG is administered 36 hours before ovum pickup and two successive doses of GnRH are administered 36 and 24 hours before ovum pickup.

干预措施: Modified dual trigger (Drug)

HCG group

Active Comparator

A single dose of HCG is administered 36 hours before oocyte retrieval

干预措施: HCG (Drug)

研究者

发起方
Bedaya Hospital
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验